{"entity":{"type":"insider","cik":"0001827672","url":"/insider/0001827672","json_url":"/insider/0001827672.json","name":"Azamian Bobak R.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":85,"n_filings":53,"first":"2021-08-06","last":"2026-06-22","span_basis":"filed_date"},"name_variants":[{"name":"Azamian Bobak R.","source":"filing","n_filings":53,"first_seen":"2021-08-06","last_seen":"2026-06-22"}],"transactions":[{"id":5937943,"accession":"0001827672-26-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001827672-26-000009","line_url":"/filing/0001827672-26-000009","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":61.548826,"price_display":"61.55","price_state":"stated","total_value":615488.26,"total_display":"615,488.26","total_whole":"615,488","shares_owned_after":847991.0,"shares_owned_after_display":"847,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-22","scope":"insider","n_lines":2},{"id":6100275,"accession":"0001827672-26-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001827672-26-000007","line_url":"/filing/0001827672-26-000007#line-3","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11964.0,"shares_display":"11,964","price_per_share":67.0,"price_display":"67.00","price_state":"stated","total_value":801588.0,"total_display":"801,588.00","total_whole":"801,588","shares_owned_after":33421.0,"shares_owned_after_display":"33,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-19","filed_date":"2026-03-19","scope":"insider"},{"id":6100272,"accession":"0001827672-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001827672-26-000007","line_url":"/filing/0001827672-26-000007#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11667.0,"shares_display":"11,667","price_per_share":68.71,"price_display":"68.71","price_state":"stated","total_value":801639.57,"total_display":"801,639.57","total_whole":"801,640","shares_owned_after":45385.0,"shares_owned_after_display":"45,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-19","scope":"insider"},{"id":6100270,"accession":"0001827672-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-26-000007","line_url":"/filing/0001827672-26-000007#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10972.0,"shares_display":"10,972","price_per_share":69.42,"price_display":"69.42","price_state":"stated","total_value":761676.24,"total_display":"761,676.24","total_whole":"761,676","shares_owned_after":57052.0,"shares_owned_after_display":"57,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":4971268,"accession":"0001827672-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001827672-25-000007","line_url":"/filing/0001827672-25-000007","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":82.51490166666666,"price_display":"82.51","price_state":"stated","total_value":495089.41,"total_display":"495,089.41","total_whole":"495,089","shares_owned_after":858548.0,"shares_owned_after_display":"858,548","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-24","filed_date":"2025-12-30","scope":"insider","n_lines":2},{"id":5220578,"accession":"0001827672-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-25-000003","line_url":"/filing/0001827672-25-000003#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":55.37,"price_display":"55.37","price_state":"stated","total_value":332220.0,"total_display":"332,220.00","total_whole":"332,220","shares_owned_after":812106.0,"shares_owned_after_display":"812,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-24","filed_date":"2025-09-26","scope":"insider"},{"id":5178721,"accession":"0001819790-25-000110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001819790-25-000110","line_url":"/filing/0001819790-25-000110#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":818106.0,"shares_owned_after_display":"818,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-08-13","scope":"insider"},{"id":4971133,"accession":"0001819790-25-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001819790-25-000061","line_url":"/filing/0001819790-25-000061#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":824106.0,"shares_owned_after_display":"824,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-26","scope":"insider"},{"id":4933437,"accession":"0001819790-25-000055","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001819790-25-000055","line_url":"/filing/0001819790-25-000055#line-3","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8534.0,"shares_display":"8,534","price_per_share":50.11,"price_display":"50.11","price_state":"stated","total_value":427638.74,"total_display":"427,638.74","total_whole":"427,639","shares_owned_after":53635.0,"shares_owned_after_display":"53,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-20","scope":"insider"},{"id":4933432,"accession":"0001819790-25-000055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001819790-25-000055","line_url":"/filing/0001819790-25-000055#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8551.0,"shares_display":"8,551","price_per_share":47.4,"price_display":"47.40","price_state":"stated","total_value":405317.4,"total_display":"405,317.40","total_whole":"405,317","shares_owned_after":62169.0,"shares_owned_after_display":"62,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-20","scope":"insider"},{"id":4933426,"accession":"0001819790-25-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001819790-25-000055","line_url":"/filing/0001819790-25-000055#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7131.0,"shares_display":"7,131","price_per_share":46.29,"price_display":"46.29","price_state":"stated","total_value":330093.99,"total_display":"330,093.99","total_whole":"330,094","shares_owned_after":70720.0,"shares_owned_after_display":"70,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-20","scope":"insider"},{"id":2050770,"accession":"0001819790-24-000045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001819790-24-000045","line_url":"/filing/0001819790-24-000045#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10415.0,"shares_display":"10,415","price_per_share":30.6,"price_display":"30.60","price_state":"stated","total_value":318699.0,"total_display":"318,699.00","total_whole":"318,699","shares_owned_after":26456.0,"shares_owned_after_display":"26,456","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-18","filed_date":"2024-03-19","scope":"insider"},{"id":8758201,"accession":"0001827672-23-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000050","line_url":"/filing/0001827672-23-000050#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":20.22,"price_display":"20.22","price_state":"stated","total_value":161760.0,"total_display":"161,760.00","total_whole":"161,760","shares_owned_after":830106.0,"shares_owned_after_display":"830,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-27","filed_date":"2023-12-29","scope":"insider"},{"id":8380119,"accession":"0001827672-23-000048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001827672-23-000048","line_url":"/filing/0001827672-23-000048","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":20.26557,"price_display":"20.27","price_state":"stated","total_value":810622.8,"total_display":"810,622.80","total_whole":"810,623","shares_owned_after":838106.0,"shares_owned_after_display":"838,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-22","scope":"insider","n_lines":2},{"id":8454272,"accession":"0001827672-23-000045","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001827672-23-000045","line_url":"/filing/0001827672-23-000045","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":18.36664,"price_display":"18.37","price_state":"stated","total_value":146933.12,"total_display":"146,933.12","total_whole":"146,933","shares_owned_after":878306.0,"shares_owned_after_display":"878,306","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider","n_lines":3},{"id":8346253,"accession":"0001827672-23-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000043","line_url":"/filing/0001827672-23-000043#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":13.24,"price_display":"13.24","price_state":"stated","total_value":105920.0,"total_display":"105,920.00","total_whole":"105,920","shares_owned_after":886106.0,"shares_owned_after_display":"886,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-18","filed_date":"2023-10-20","scope":"insider"},{"id":8212501,"accession":"0001827672-23-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000041","line_url":"/filing/0001827672-23-000041#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":17.21,"price_display":"17.21","price_state":"stated","total_value":137680.0,"total_display":"137,680.00","total_whole":"137,680","shares_owned_after":894106.0,"shares_owned_after_display":"894,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-20","filed_date":"2023-09-22","scope":"insider"},{"id":8029719,"accession":"0001827672-23-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000039","line_url":"/filing/0001827672-23-000039#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":17.23,"price_display":"17.23","price_state":"stated","total_value":137840.0,"total_display":"137,840.00","total_whole":"137,840","shares_owned_after":902106.0,"shares_owned_after_display":"902,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-23","filed_date":"2023-08-25","scope":"insider"},{"id":8380112,"accession":"0001827672-23-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001827672-23-000037","line_url":"/filing/0001827672-23-000037","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103900.0,"shares_display":"103,900","price_per_share":20.00946833493744,"price_display":"20.01","price_state":"stated","total_value":2078983.76,"total_display":"2,078,983.76","total_whole":"2,078,984","shares_owned_after":910106.0,"shares_owned_after_display":"910,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-21","scope":"insider","n_lines":2},{"id":8090062,"accession":"0001827672-23-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000035","line_url":"/filing/0001827672-23-000035#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":17.35,"price_display":"17.35","price_state":"stated","total_value":156150.0,"total_display":"156,150.00","total_whole":"156,150","shares_owned_after":1014006.0,"shares_owned_after_display":"1,014,006","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-14","scope":"insider"},{"id":8131850,"accession":"0001819790-23-000048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001819790-23-000048","line_url":"/filing/0001819790-23-000048#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":18.63,"price_display":"18.63","price_state":"stated","total_value":149040.0,"total_display":"149,040.00","total_whole":"149,040","shares_owned_after":1023006.0,"shares_owned_after_display":"1,023,006","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-23","scope":"insider"},{"id":7953588,"accession":"0001827672-23-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000033","line_url":"/filing/0001827672-23-000033#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":18.58,"price_display":"18.58","price_state":"stated","total_value":167220.0,"total_display":"167,220.00","total_whole":"167,220","shares_owned_after":1031006.0,"shares_owned_after_display":"1,031,006","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-16","scope":"insider"},{"id":7998456,"accession":"0001209191-23-036433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-036433","line_url":"/filing/0001209191-23-036433#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":20.01,"price_display":"20.01","price_state":"stated","total_value":62031.0,"total_display":"62,031.00","total_whole":"62,031","shares_owned_after":1040006.0,"shares_owned_after_display":"1,040,006","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-12","scope":"insider"},{"id":8131896,"accession":"0001827672-23-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000031","line_url":"/filing/0001827672-23-000031#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":15.9,"price_display":"15.90","price_state":"stated","total_value":127200.0,"total_display":"127,200.00","total_whole":"127,200","shares_owned_after":1043106.0,"shares_owned_after_display":"1,043,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-19","scope":"insider"},{"id":8182079,"accession":"0001827672-23-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000030","line_url":"/filing/0001827672-23-000030#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":16.8,"price_display":"16.80","price_state":"stated","total_value":151200.0,"total_display":"151,200.00","total_whole":"151,200","shares_owned_after":1051106.0,"shares_owned_after_display":"1,051,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-10","filed_date":"2023-05-12","scope":"insider"},{"id":8641639,"accession":"0001827672-23-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001827672-23-000028","line_url":"/filing/0001827672-23-000028#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5841.0,"shares_display":"5,841","price_per_share":15.1,"price_display":"15.10","price_state":"stated","total_value":88199.1,"total_display":"88,199.10","total_whole":"88,199","shares_owned_after":1060106.0,"shares_owned_after_display":"1,060,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-02","scope":"insider"},{"id":8641636,"accession":"0001827672-23-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000028","line_url":"/filing/0001827672-23-000028#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4278.0,"shares_display":"4,278","price_per_share":15.13,"price_display":"15.13","price_state":"stated","total_value":64726.14,"total_display":"64,726.14","total_whole":"64,726","shares_owned_after":1065947.0,"shares_owned_after_display":"1,065,947","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-28","filed_date":"2023-05-02","scope":"insider"},{"id":7937211,"accession":"0001827672-23-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000026","line_url":"/filing/0001827672-23-000026#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2311.0,"shares_display":"2,311","price_per_share":15.03,"price_display":"15.03","price_state":"stated","total_value":34734.33,"total_display":"34,734.33","total_whole":"34,734","shares_owned_after":1070225.0,"shares_owned_after_display":"1,070,225","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-21","filed_date":"2023-04-25","scope":"insider"},{"id":8454256,"accession":"0001827672-23-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000024","line_url":"/filing/0001827672-23-000024#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":13.6,"price_display":"13.60","price_state":"stated","total_value":108800.0,"total_display":"108,800.00","total_whole":"108,800","shares_owned_after":1072536.0,"shares_owned_after_display":"1,072,536","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-19","filed_date":"2023-04-21","scope":"insider"},{"id":8380104,"accession":"0001827672-23-000022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001827672-23-000022","line_url":"/filing/0001827672-23-000022#line-3","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":737.0,"shares_display":"737","price_per_share":12.15,"price_display":"12.15","price_state":"stated","total_value":8954.55,"total_display":"8,954.55","total_whole":"8,955","shares_owned_after":8597.0,"shares_owned_after_display":"8,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-03-23","scope":"insider"},{"id":8380101,"accession":"0001827672-23-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001827672-23-000022","line_url":"/filing/0001827672-23-000022#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":709.0,"shares_display":"709","price_per_share":12.64,"price_display":"12.64","price_state":"stated","total_value":8961.76,"total_display":"8,961.76","total_whole":"8,962","shares_owned_after":9334.0,"shares_owned_after_display":"9,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-22","filed_date":"2023-03-23","scope":"insider"},{"id":8380096,"accession":"0001827672-23-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000022","line_url":"/filing/0001827672-23-000022#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":679.0,"shares_display":"679","price_per_share":12.89,"price_display":"12.89","price_state":"stated","total_value":8752.31,"total_display":"8,752.31","total_whole":"8,752","shares_owned_after":10043.0,"shares_owned_after_display":"10,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-21","filed_date":"2023-03-23","scope":"insider"},{"id":8090060,"accession":"0001827672-23-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001827672-23-000020","line_url":"/filing/0001827672-23-000020#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":741.0,"shares_display":"741","price_per_share":12.61,"price_display":"12.61","price_state":"stated","total_value":9344.01,"total_display":"9,344.01","total_whole":"9,344","shares_owned_after":10722.0,"shares_owned_after_display":"10,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-21","scope":"insider"},{"id":8090059,"accession":"0001827672-23-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000020","line_url":"/filing/0001827672-23-000020#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":795.0,"shares_display":"795","price_per_share":13.28,"price_display":"13.28","price_state":"stated","total_value":10557.6,"total_display":"10,557.60","total_whole":"10,558","shares_owned_after":11463.0,"shares_owned_after_display":"11,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-21","scope":"insider"},{"id":8050208,"accession":"0001827672-23-000018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001827672-23-000018","line_url":"/filing/0001827672-23-000018#line-3","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":791.0,"shares_display":"791","price_per_share":13.43,"price_display":"13.43","price_state":"stated","total_value":10623.13,"total_display":"10,623.13","total_whole":"10,623","shares_owned_after":12258.0,"shares_owned_after_display":"12,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-17","scope":"insider"},{"id":8050204,"accession":"0001827672-23-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001827672-23-000018","line_url":"/filing/0001827672-23-000018#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":13.79,"price_display":"13.79","price_state":"stated","total_value":110320.0,"total_display":"110,320.00","total_whole":"110,320","shares_owned_after":1080536.0,"shares_owned_after_display":"1,080,536","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-17","scope":"insider"},{"id":8240813,"accession":"0001827672-23-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001827672-23-000016","line_url":"/filing/0001827672-23-000016#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":717.0,"shares_display":"717","price_per_share":15.01,"price_display":"15.01","price_state":"stated","total_value":10762.17,"total_display":"10,762.17","total_whole":"10,762","shares_owned_after":1088536.0,"shares_owned_after_display":"1,088,536","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-09","filed_date":"2023-03-10","scope":"insider"},{"id":8240809,"accession":"0001827672-23-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000016","line_url":"/filing/0001827672-23-000016#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4853.0,"shares_display":"4,853","price_per_share":15.02,"price_display":"15.02","price_state":"stated","total_value":72892.06,"total_display":"72,892.06","total_whole":"72,892","shares_owned_after":1089253.0,"shares_owned_after_display":"1,089,253","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-08","filed_date":"2023-03-10","scope":"insider"},{"id":8595274,"accession":"0001827672-23-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000014","line_url":"/filing/0001827672-23-000014#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":15.28,"price_display":"15.28","price_state":"stated","total_value":122240.0,"total_display":"122,240.00","total_whole":"122,240","shares_owned_after":1094106.0,"shares_owned_after_display":"1,094,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-15","filed_date":"2023-02-17","scope":"insider"},{"id":8758198,"accession":"0001827672-23-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000012","line_url":"/filing/0001827672-23-000012#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":15.14,"price_display":"15.14","price_state":"stated","total_value":136260.0,"total_display":"136,260.00","total_whole":"136,260","shares_owned_after":1102106.0,"shares_owned_after_display":"1,102,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-10","scope":"insider"},{"id":8008366,"accession":"0001827672-23-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000010","line_url":"/filing/0001827672-23-000010#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4856.0,"shares_display":"4,856","price_per_share":15.45,"price_display":"15.45","price_state":"stated","total_value":75025.2,"total_display":"75,025.20","total_whole":"75,025","shares_owned_after":1111106.0,"shares_owned_after_display":"1,111,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":7937210,"accession":"0001827672-23-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001827672-23-000006","line_url":"/filing/0001827672-23-000006#line-2","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":240.0,"shares_display":"240","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3600.0,"total_display":"3,600.00","total_whole":"3,600","shares_owned_after":1116373.0,"shares_owned_after_display":"1,116,373","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-20","scope":"insider"},{"id":7937207,"accession":"0001827672-23-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000006","line_url":"/filing/0001827672-23-000006#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":14.56,"price_display":"14.56","price_state":"stated","total_value":116480.0,"total_display":"116,480.00","total_whole":"116,480","shares_owned_after":1116613.0,"shares_owned_after_display":"1,116,613","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-20","scope":"insider"},{"id":8513396,"accession":"0001827672-23-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001827672-23-000004","line_url":"/filing/0001827672-23-000004#line-1","is_derivative":false,"issuer_cik":"0001819790","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001819790","owner_cik":"0001827672","owner_name":"Azamian Bobak R.","owner_display_name":"Azamian Bobak R.","owner_url":"/insider/0001827672","role":"Director, Officer (President/CEO and Board Chair)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President/CEO and Board Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3904.0,"shares_display":"3,904","price_per_share":15.11,"price_display":"15.11","price_state":"stated","total_value":58989.44,"total_display":"58,989.44","total_whole":"58,989","shares_owned_after":1124613.0,"shares_owned_after_display":"1,124,613","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-13","scope":"insider"}],"collapsed":true,"next_cursor":"2023-01-11|8513396","ledger_fault":false,"count":{"value":85,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":85,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":85},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819790","name":"Tarsus Pharmaceuticals, Inc.","url":"/issuer/0001819790","role":"Director, Officer (President/CEO and Board Chair)","n_filings":53,"first_seen":"2021-08-06","last_seen":"2026-06-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001827672","retrieved_at":"2026-08-27T07:39:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}